Rosemary Mazanet, M.D. PhD, is a clinician scientist with decades of experience in clinical development and healthcare investing. After training at the Brigham and Women’s Hospital and the Dana-Farber Cancer Institute where she was on clinical faculty, she joined “early” Amgen, she was given broad responsibilities to leading several product development initiatives, including FDA panel presentations resulting in successful product approvals. She subsequently joined Oracle Partners LLC in New York as a General Partner and has been a presence in public equity and private equity biotech and specialty pharma since that time.
In addition to serving as a life sciences management and investment professional, Rosemary has served as a C Suite executive at several companies and led development programs ranging from IND submission through NDA approval and commercial launch. Her ability to conceive, articulate and execute strategic development and financial vision in public and private company environments enables her to guide Columbia Care’s research efforts, including at many of the top national academic sites. Among the many boards she participates on, Dr Mazanet is a Charter Trustee at the University of Pennsylvania Health System, and is the Co-Chair of the Leonard Davis Institute Executive Advisory Board at Wharton.